{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:40:07Z","timestamp":1777574407364,"version":"3.51.4"},"reference-count":10,"publisher":"American Academy of Pediatrics (AAP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Penicillin allergy labels are often inaccurate in children and removing unnecessary labels results in improved outcomes and lower health care costs. Although the hospital setting is a frequent point of contact for children, strategies to evaluate penicillin allergies in the hospital are lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We performed a prospective pilot study to determine the feasibility of a centralized, pharmacy-led approach to penicillin allergy evaluation. Children with a reported history of penicillin allergy admitted to our children\u2019s hospital were risk-stratified and those stratified as low-risk underwent a single-dose oral challenge by a central pharmacist, regardless of the need for antibiotics. After the completion of each patient\u2019s delabeling process, surveys were distributed to health care personnel involved in the patient\u2019s care to collect perceptions on the acceptability, appropriateness, and feasibility of this intervention. Measures were scored by using a 5-point Likert scale.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Of the 23 patients who screened as low-risk, 20 underwent a penicillin allergy evaluation and an oral challenge. Of these, the penicillin allergy label was removed in 19 (95%) patients (Fig 1). The median age was 7 years (range 11 months\u201318 years). Participants rated the risk stratification and delabeling favorably overall, with high ratings on all 3 implementation measures: acceptability (mean 4.55, \u00b1 standard deviation [STD] 0.65), appropriateness (mean 4.58, STD \u00b1 0.6), and feasibility (mean 4.51, STD \u00b1 0.73). Measures of acceptability, appropriateness, and feasibility remained high when stratified by health care worker type and provider type.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Our findings provide support for systemic implementation of penicillin allergy delabeling strategies in hospitalized children.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2021-006369","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T08:11:59Z","timestamp":1654762319000},"page":"e230-e237","source":"Crossref","is-referenced-by-count":16,"title":["Feasibility of a Centralized, Pharmacy-Led Penicillin Allergy Delabeling Program"],"prefix":"10.1542","volume":"12","author":[{"given":"James W.","family":"Antoon","sequence":"first","affiliation":[{"name":"aDivision of Hospital Medicine, Monroe Carell Jr. Children\u2019s Hospital at Vanderbilt, Nashville, Tennessee"},{"name":"bDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[{"name":"cDepartment of Health Policy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison G.","family":"Grisso","sequence":"additional","affiliation":[{"name":"dDepartment of Pharmacy, Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosby A.","family":"Stone","sequence":"additional","affiliation":[{"name":"eDivision of Allergy & Immunology, Departments of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakobi","family":"Johnson","sequence":"additional","affiliation":[{"name":"aDivision of Hospital Medicine, Monroe Carell Jr. Children\u2019s Hospital at Vanderbilt, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Stassun","sequence":"additional","affiliation":[{"name":"aDivision of Hospital Medicine, Monroe Carell Jr. Children\u2019s Hospital at Vanderbilt, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison E.","family":"Norton","sequence":"additional","affiliation":[{"name":"fPediatrics and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kripalani","sequence":"additional","affiliation":[{"name":"gDivision of General Internal Medicine and Public Health, Department of Medicine, and Center for Clinical Quality and Implementation Research, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek J.","family":"Williams","sequence":"additional","affiliation":[{"name":"aDivision of Hospital Medicine, Monroe Carell Jr. Children\u2019s Hospital at Vanderbilt, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"issue":"6","key":"2023112014481942800_b1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.anai.2020.03.012","article-title":"Children with reported penicillin allergy: public health impact and safety of delabeling","volume":"124","author":"Vyles","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"2023112014481942800_b2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2023112014481942800_b3","doi-asserted-by":"crossref","first-page":"e20173466","DOI":"10.1542\/peds.2017-3466","article-title":"Antibiotic use after removal of penicillin allergy label","volume":"141","author":"Vyles","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"2023112014481942800_b4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/ice.2020.1267","article-title":"Pediatric research priorities in healthcare-associated infections and antimicrobial stewardship","volume":"42","author":"Coffin","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"2023112014481942800_b5","doi-asserted-by":"crossref","first-page":"e20170471","DOI":"10.1542\/peds.2017-0471","article-title":"Allergy testing in children with low-risk penicillin allergy symptoms","volume":"140","author":"Vyles","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"2023112014481942800_b6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jaip.2019.09.022","article-title":"Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit","volume":"8","author":"Vyles","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2023112014481942800_b7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13012-017-0635-3","article-title":"Psychometric assessment of three newly developed implementation outcome measures","volume":"12","author":"Weiner","year":"2017","journal-title":"Implement Sci"},{"issue":"12","key":"2023112014481942800_b8","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1164\/rccm.202001-0089LE","article-title":"Risk-stratified management to remove low-risk penicillin allergy labels in the ICU","volume":"201","author":"Stone","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2023112014481942800_b9","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1542\/hpeds.2020-005280","article-title":"Breaking the mold: safely delabeling penicillin allergies in hospitalized children","volume":"11","author":"Antoon","year":"2021","journal-title":"Hosp Pediatr"},{"issue":"5","key":"2023112014481942800_b10","doi-asserted-by":"crossref","first-page":"e20200858","DOI":"10.1542\/peds.2020-0858","article-title":"Prevalence of clinically significant drug-drug interactions across US children\u2019s hospitals","volume":"146","author":"Antoon","year":"2020","journal-title":"Pediatrics"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/7\/e230\/1573471\/hpeds.2021-006369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/7\/e230\/1573471\/hpeds.2021-006369.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:49:24Z","timestamp":1700491764000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/12\/7\/e230\/188258\/Feasibility-of-a-Centralized-Pharmacy-Led"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":10,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,6,9]]},"published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2021-006369","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]}}}